Nasus Pharma Ltd.
NSRX | AMEX
$3.16
-$0.15 (-4.53%)
At close: Oct 30, 2026, 3:59 PM ET
$3.16
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 3:59 PM ET
TTM Period Ending | TTM 2026 Jun 30, 2026 | TTM 2026 Mar 31, 2026 | TTM 2025 Dec 31, 2025 | TTM 2025 Sep 30, 2025 | TTM 2025 Jun 30, 2025 | TTM 2025 Mar 31, 2025 | TTM 2024 Dec 31, 2024 | TTM 2024 Sep 30, 2024 | TTM 2024 Jun 30, 2024 | TTM 2024 Mar 31, 2024 | TTM 2023 Dec 31, 2023 | TTM 2023 Sep 30, 2023 | TTM 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -3.65 | -4.44 | -12.71 | n/a | -31.73 | -34.38 | -48.53 | -35.87 | -33 | -41.25 | -68.75 | -95.49 | -43.42 |
PEG Ratio | -0.04 | -0.06 | -0.04 | n/a | n/a | -0.46 | -1.16 | 1.30 | n/a | -5.34 | 1.87 | -0.28 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.52 | 2.22 | 26.48 | n/a | n/a | n/a | n/a | n/a | -11.85 | n/a | n/a | n/a | n/a |
P/FCF Ratio | -11.52 | -16.35 | -14.86 | n/a | -525.79 | -80.47K | -112.39 | -83.87K | -75.51K | -62.78K | -72.64 | -76.96K | -61.72 |
P/OCF Ratio | -11.54 | -16.39 | -14.90 | n/a | -525.78 | -80.47K | -112.39 | -83.87K | -75.51K | -62.78K | -72.64 | -76.96K | -61.72 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.04 | 0.04 | n/a | n/a | n/a | n/a | -0.82 | n/a | n/a | n/a | n/a |
Quick Ratio | 8.77 | 8.77 | 2.24 | 2.24 | n/a | n/a | n/a | n/a | 0.16 | n/a | n/a | n/a | n/a |
Current Ratio | 8.77 | 8.77 | 2.24 | 2.24 | n/a | n/a | n/a | n/a | 0.16 | n/a | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | -37.17 | n/a | n/a | n/a | -23.41 | n/a | -113.44 |
Return on Equity | -149.74% | -90.53% | -95.52% | 10.29% | 10.29% | 19.63% | n/a | 9.34% | 9.34% | n/a | n/a | n/a | n/a |
Return on Assets | -82.78% | -40.08% | -52.84% | -46.09% | -46.09% | -88.79% | -213.67% | -42.70% | -167.45% | n/a | n/a | n/a | n/a |
Return on Invested Capital | -73.29% | -33.20% | -56.19% | 21.10% | 21.10% | 49.21% | n/a | 28.11% | 28.11% | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NSRX